204 related articles for article (PubMed ID: 18780599)
21. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
22. Specific treatment of Prader-Willi syndrome through cyclical rehabilitation programmes.
Grolla E; Andrighetto G; Parmigiani P; Hladnik U; Ferrari G; Bernardelle R; Lago MD; Albarello A; Baschirotto G; Filippi G; Lovato R; Dolcetta D
Disabil Rehabil; 2011; 33(19-20):1837-47. PubMed ID: 21269146
[TBL] [Abstract][Full Text] [Related]
23. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
[TBL] [Abstract][Full Text] [Related]
24. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
25. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
[TBL] [Abstract][Full Text] [Related]
26. The modified Atkins diet in children with Prader-Willi syndrome.
Felix G; Kossoff E; Barron B; Krekel C; Testa EG; Scheimann A
Orphanet J Rare Dis; 2020 Jun; 15(1):135. PubMed ID: 32493369
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of obesity in Prader-Willi syndrome.
Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
[TBL] [Abstract][Full Text] [Related]
28. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome.
McAlister KL; Fisher KL; Dumont-Driscoll MC; Rubin DA
J Pediatr Endocrinol Metab; 2018 Aug; 31(8):837-845. PubMed ID: 29975666
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome in adult patients with Prader-Willi syndrome.
Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
[TBL] [Abstract][Full Text] [Related]
30. Premature adrenarche in Prader-Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age.
Gaston LS; Stafford DE
J Pediatr Endocrinol Metab; 2023 Feb; 36(2):185-194. PubMed ID: 36458449
[TBL] [Abstract][Full Text] [Related]
31. Effects of 5 years growth hormone treatment in patients with Prader-Willi syndrome.
Obata K; Sakazume S; Yoshino A; Murakami N; Sakuta R
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):155-62. PubMed ID: 12713251
[TBL] [Abstract][Full Text] [Related]
32. Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study.
Corripio R; Tubau C; Calvo L; Brun C; Capdevila N; Larramona H; Gabau E
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):879-884. PubMed ID: 31271556
[TBL] [Abstract][Full Text] [Related]
33. Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome.
Mele C; Crinò A; Fintini D; Mai S; Convertino A; Bocchini S; Di Paolo P; Grugni G; Aimaretti G; Scacchi M; Marzullo P
J Endocrinol Invest; 2021 Jul; 44(7):1447-1456. PubMed ID: 33067796
[TBL] [Abstract][Full Text] [Related]
34. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
35. A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome.
Miller JL; Lynn CH; Shuster J; Driscoll DJ
J Hum Nutr Diet; 2013 Feb; 26(1):2-9. PubMed ID: 23078343
[TBL] [Abstract][Full Text] [Related]
36. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
[TBL] [Abstract][Full Text] [Related]
37. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.
Lin HY; Lin SP; Tsai LP; Chao MC; Chen MR; Chuang CK; Huang CY; Tsai FJ; Chou IC; Chiu PC; Huang CH; Yen JL; Lin JL; Kuo PL
J Chin Med Assoc; 2008 Jun; 71(6):305-9. PubMed ID: 18567561
[TBL] [Abstract][Full Text] [Related]
38. Understanding the causes of obesity in children with trisomy 21: hyperphagia vs physical inactivity.
Foerste T; Sabin M; Reid S; Reddihough D
J Intellect Disabil Res; 2016 Sep; 60(9):856-64. PubMed ID: 26936540
[TBL] [Abstract][Full Text] [Related]
39. Early Diagnosis in Prader-Willi Syndrome Reduces Obesity and Associated Co-Morbidities.
Kimonis VE; Tamura R; Gold JA; Patel N; Surampalli A; Manazir J; Miller JL; Roof E; Dykens E; Butler MG; Driscoll DJ
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31698873
[TBL] [Abstract][Full Text] [Related]
40. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]